Advancing the Science of Intermediates.
Our R&D focus is simple: make better molecules, cleaner processes, and more reliable supply for the industries that depend on us.
Research That Drives Real-World Results
Our internal R&D programme covers new intermediate development, yield and purity optimisation, and process intensification. We work closely with client technical teams to translate laboratory findings into commercially viable production pathways.
Current development focus areas include pharmaceutical contrast media intermediates (5-NIPA, 5-HIPA, SSIPA) and advanced dye intermediates for next-generation reactive and direct dye systems.
Greener Chemistry. Better Outcomes.
PILLAR 1
Zero-Discharge Operations — Our ETP and STP infrastructure ensures no untreated effluent exits our facility.
PILLAR 2
Renewable Energy Integration — Solar and wind inputs reduce our grid dependency and carbon emissions.
PILLAR 3
Responsible Sourcing — Raw material procurement governed by quality, traceability, and environmental criteria.
PILLAR 4
Process Efficiency — Continuous improvement in atom economy and solvent recovery across all production lines.
In the Pipeline
We’re investing in tomorrow’s chemistry today. The following intermediates are in active development — contact us to discuss availability timelines.
PRODUCTS
5-Nitroisophthalic Acid (5-NIPA) — Contrast media and high-performance polymer intermediate.
5-Hydroxyisophthalic Acid (5-HIPA) — X-ray contrast agent intermediate and MOF linker.
Dimethyl 5-Nitroisophthalic Acid (5-NIPA DME) — Key API intermediate for Iohexol, Iopamidol, and Ioversol.
5-Sulfoisophthalic Acid Monosodium Salt (SSIPA) — Water-dispersible polyester resin intermediate.
Copper Formazone of Hydrazone of 5-Sulpho Anthranilic Acid — Advanced campaign-base intermediate.
Looking to Co-Develop a New Intermediate?
Our team is open to collaborative R&D projects with global partners.
- Advancing Chemistry with Purpose
At Rudra Industries, research is not confined to the laboratory — it is built to translate into scalable, real-world solutions. Our R&D efforts focus on developing new intermediates, enhancing yield and purity, and refining processes for greater efficiency and reliability.
Working in close collaboration with client technical teams, we bridge the gap between concept and commercial production. Our approach ensures that every development is practical, cost-effective, and ready for industrial application.
Our current focus areas include advanced pharmaceutical intermediates such as contrast media compounds, along with next-generation dye intermediates designed for high-performance applications.
